Silence Therapeutics Plc Stock Market Value
| SLN Stock | USD 6.45 0.15 2.27% |
| Symbol | Silence |
Silence Therapeutics PLC Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silence Therapeutics. If investors know Silence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silence Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.76) | Revenue Per Share 0.429 | Quarterly Revenue Growth (0.93) | Return On Assets (0.22) | Return On Equity (0.64) |
The market value of Silence Therapeutics PLC is measured differently than its book value, which is the value of Silence that is recorded on the company's balance sheet. Investors also form their own opinion of Silence Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Silence Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silence Therapeutics' market value can be influenced by many factors that don't directly affect Silence Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silence Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Silence Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silence Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Silence Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Silence Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Silence Therapeutics.
| 11/19/2023 |
| 12/13/2024 |
If you would invest 0.00 in Silence Therapeutics on November 19, 2023 and sell it all today you would earn a total of 0.00 from holding Silence Therapeutics PLC or generate 0.0% return on investment in Silence Therapeutics over 390 days. Silence Therapeutics is related to or competes with Puma Biotechnology, Iovance Biotherapeutics, Day One, Inozyme Pharma, Zentalis Pharmaceuticals, Syndax Pharmaceuticals, and Protagonist Therapeutics. Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid th... More
Silence Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Silence Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Silence Therapeutics PLC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 41.48 | |||
| Value At Risk | (9.16) | |||
| Potential Upside | 4.7 |
Silence Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Silence Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Silence Therapeutics' standard deviation. In reality, there are many statistical measures that can use Silence Therapeutics historical prices to predict the future Silence Therapeutics' volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (1.53) | |||
| Total Risk Alpha | (2.21) | |||
| Treynor Ratio | (0.72) |
Silence Therapeutics PLC Backtested Returns
Silence Therapeutics PLC owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.22, which indicates the firm had a -0.22% return per unit of risk over the last 3 months. Silence Therapeutics PLC exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Silence Therapeutics' Risk Adjusted Performance of (0.15), coefficient of variation of (461.79), and Variance of 37.88 to confirm the risk estimate we provide. The entity has a beta of 1.86, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Silence Therapeutics will likely underperform. At this point, Silence Therapeutics PLC has a negative expected return of -1.38%. Please make sure to validate Silence Therapeutics' information ratio, skewness, as well as the relationship between the Skewness and day typical price , to decide if Silence Therapeutics PLC performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.35 |
Poor reverse predictability
Silence Therapeutics PLC has poor reverse predictability. Overlapping area represents the amount of predictability between Silence Therapeutics time series from 19th of November 2023 to 1st of June 2024 and 1st of June 2024 to 13th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Silence Therapeutics PLC price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current Silence Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.35 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 15.1 |
Silence Therapeutics PLC lagged returns against current returns
Autocorrelation, which is Silence Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Silence Therapeutics' stock expected returns. We can calculate the autocorrelation of Silence Therapeutics returns to help us make a trade decision. For example, suppose you find that Silence Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Silence Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Silence Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Silence Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Silence Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Silence Therapeutics Lagged Returns
When evaluating Silence Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Silence Therapeutics stock have on its future price. Silence Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Silence Therapeutics autocorrelation shows the relationship between Silence Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Silence Therapeutics PLC.
Regressed Prices |
| Timeline |
Pair Trading with Silence Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Silence Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silence Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Silence Stock
Moving against Silence Stock
| 0.84 | DYAI | Dyadic International | PairCorr |
| 0.78 | ESPR | Esperion Therapeutics | PairCorr |
| 0.77 | BMY | Bristol Myers Squibb | PairCorr |
| 0.57 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
| 0.37 | DNA | Ginkgo Bioworks Holdings | PairCorr |
The ability to find closely correlated positions to Silence Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Silence Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Silence Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Silence Therapeutics PLC to buy it.
The correlation of Silence Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Silence Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Silence Therapeutics PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Silence Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Silence Therapeutics Correlation, Silence Therapeutics Volatility and Silence Therapeutics Alpha and Beta module to complement your research on Silence Therapeutics. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Silence Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.